Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biotalys NV's Enterprise Value is €108.45 Mil.
Biotalys NV's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-15.65 Mil. Therefore, Biotalys NV's EV-to-EBIT ratio for today is -6.93.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Biotalys NV's Enterprise Value is €108.45 Mil.
Biotalys NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €-13.86 Mil. Therefore, Biotalys NV's EV-to-EBITDA ratio for today is -7.82.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Biotalys NV's Enterprise Value is €108.45 Mil.
Biotalys NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil. Therefore, Biotalys NV's EV-to-Revenue ratio for today is .
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Biotalys NV's Enterprise Value is €108.45 Mil.
Biotalys NV's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-13.86 Mil. Therefore, Biotalys NV's EV-to-FCF ratio for today is -7.82.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Biotalys NV (FRA:86C) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Biotalys NV's current Enterprise Value is €108.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biotalys NV's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-15.65 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Biotalys NV's current Enterprise Value is €108.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biotalys NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €-13.86 Mil.
Biotalys NV's current Enterprise Value is €108.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biotalys NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.
Biotalys NV's current Enterprise Value is €108.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biotalys NV's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €-13.68 Mil.
Biotalys NV's current Enterprise Value is €108.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biotalys NV's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-13.86 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotalys NV Enterprise Value Related Terms
Biotalys NV Enterprise Value Historical Data
* Premium members only.
The historical data trend for Biotalys NV's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:86C vs CTVA, CF, MOS: Enterprise Value Comparison
For the Agricultural Inputs subindustry, Biotalys NV's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotalys NV Enterprise Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Biotalys NV's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Biotalys NV's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Biotalys NV's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotalys NV (FRA:86C) has a Enterprise Value of €108.45 Mil as of Aug. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Biotalys NV and its competitors.
Is Biotalys NV's Enterprise Value too high?
Biotalys NV's current Enterprise Value is €108.45 Mil. Overall, Biotalys NV has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Biotalys NV's Enterprise Value compare to CTVA and CF?
Biotalys NV's Enterprise Value of €108.45 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for an Agriculture company?
A good Enterprise Value depends on the Agriculture industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Biotalys NV and its competitors. Biotalys NV's current Enterprise Value is €108.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotalys NV stock overvalued right now?
Biotalys NV (FRA:86C) has a current Enterprise Value of €108.45 Mil. The current Enterprise Value is €108.45 Mil. Biotalys NV's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Biotalys NV (FRA:86C), the current Enterprise Value is €108.45 Mil as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biotalys NV is an Agricultural Technology (AgTech) company developing Precision Biocontrol solutions based on proteins for the protection of crops in both the pre and post harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Its pipeline EVOCA 1st Gen, EVOCA NG, BioFun-6, and BioFun-7. It operates in single segment.
37GF Score
Get the complete analysis for FRA:86C
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:86C has been successfully added to your 
